Cyclacel Pharmaceuticals, Inc. (CYCC)

NASDAQ: CYCC · IEX Real-Time Price · USD

1.600

-0.680 (-29.82%)

At close: Apr 25, 2024, 4:00 PM

1.510

-0.090 (-5.63%)

After-hours: Apr 25, 2024, 7:59 PM EDT

Cyclacel Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2001
Revenue	0.42	0	0	0	0	0.15	0	0.84	1.94	1.73	Upgrade
Revenue Growth (YoY)	-	-	-	-	-	-	-	-56.64%	12.11%	59.96%	Upgrade
Gross Profit	0.42	0	0	0	0	0.15	0	0.84	1.94	1.73	Upgrade
Selling, General & Admin	6.72	7.38	7.46	5.88	5.02	5.37	5.25	5.52	5.73	5.89	Upgrade
Research & Development	19.16	20.27	14.93	4.76	4.66	4.33	4.24	9.48	12.38	18.28	Upgrade
Operating Expenses	25.87	27.66	22.39	10.64	9.68	9.7	9.49	14.99	18.11	24.17	Upgrade
Operating Income	-25.45	-27.66	-22.39	-10.64	-9.68	-9.55	-9.49	-14.15	-16.17	-22.44	Upgrade
Other Expense / Income	0.1	-1.74	-0.2	-0.96	-0.56	-0.92	-1.03	-0.38	0.32	0.19	Upgrade
Pretax Income	-25.55	-25.92	-22.19	-9.68	-9.13	-8.63	-8.46	-13.77	-16.49	-22.63	Upgrade
Income Tax	-3	-4.72	-3.73	-1.24	-1.3	-1.34	-0.99	-1.98	-2.14	-3.24	Upgrade
Net Income	-22.56	-21.2	-18.46	-8.45	-7.83	-7.29	-7.47	-11.79	-14.34	-19.39	Upgrade
Preferred Dividends	0.2	0.2	0.2	3.98	0.2	0.2	7.38	0.2	0.2	0.2	Upgrade
Net Income Common	-22.76	-21.4	-18.66	-12.42	-8.03	-7.49	-14.85	-11.99	-14.54	-19.59	Upgrade
Shares Outstanding (Basic)	1	1	1	0	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	-	1	1	0	0	0	0	0	0	0	Upgrade
Shares Change	12.32%	26.10%	145.67%	345.23%	34.95%	58.49%	122.80%	26.24%	48.29%	44.83%	Upgrade
EPS (Basic)	-26.75	-28.70	-31.35	-51.30	-147.60	-186.00	-585.00	-1050.00	-1608.00	-3204.00	Upgrade
EPS (Diluted)	-26.75	-28.70	-31.35	-51.30	-147.60	-186.00	-585.00	-1050.00	-1608.00	-3204.00	Upgrade
Free Cash Flow	-16.12	-20.83	-18.57	-8.03	-9.42	-6.74	-7.49	-10.07	-14.49	-19.01	Upgrade
Free Cash Flow Per Share	-19.12	-27.77	-31.20	-33.15	-173.13	-167.19	-294.57	-882.05	-1602.67	-3117.21	Upgrade
Gross Margin	100.00%	-	-	-	-	100.00%	-	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-6060.24%	-	-	-	-	-6365.33%	-	-1678.53%	-831.79%	-1293.94%	Upgrade
Profit Margin	-5418.10%	-	-	-	-	-4992.67%	-	-1422.42%	-748.10%	-1129.58%	Upgrade
Free Cash Flow Margin	-3837.62%	-	-	-	-	-4493.33%	-	-1194.54%	-745.58%	-1096.37%	Upgrade
EBITDA	-25.52	-25.88	-22.14	-9.66	-9.11	-8.6	-8.43	-13.64	-16.28	-22.46	Upgrade
EBITDA Margin	-6076.19%	-	-	-	-	-5730.67%	-	-1618.15%	-837.24%	-1295.04%	Upgrade
Depreciation & Amortization	0.03	0.03	0.04	0.02	0.02	0.03	0.03	0.13	0.21	0.17	Upgrade
EBIT	-25.55	-25.92	-22.19	-9.68	-9.13	-8.63	-8.46	-13.77	-16.49	-22.63	Upgrade
EBIT Margin	-6083.57%	-	-	-	-	-5750.00%	-	-1633.93%	-848.05%	-1305.07%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).